NEW YORK (GenomeWeb News) – Singulex today announced it secured $55 million in debt and equity financing.

The company secured a $40 million debt facility from Oxford Finance and Silicon Valley Bank, and in June, it raised $15 million in equity financing. Singulex said it plans to use the financing to further develop its in vitro diagnostics business based on its Single Molecule Counting technology.

The Alameda, Calif.-based company raised $19 million in a financing round in January 2009.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.